What is Oaktree Acquisition Corp. III Life Sciences's (OACC) StockRank?

MoatMap's StockRank for Oaktree Acquisition Corp. III Life Sciences (OACC) is 13/100, with a Strong Sell signal. This is a composite score combining Quality (20), Value (33), and Momentum (46) factor ranks across MoatMap's 20,000+ stock universe.

Does Oaktree Acquisition Corp. III Life Sciences have an economic moat?

Oaktree Acquisition Corp. III Life Sciences (OACC) has a Quality factor score of 20/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Oaktree Acquisition Corp. III Life Sciences a buy, hold, or sell?

MoatMap's current signal for Oaktree Acquisition Corp. III Life Sciences (OACC) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Oaktree Acquisition Corp. III Life Sciences in?

Oaktree Acquisition Corp. III Life Sciences (OACC) operates in the Financial Services sector, specifically the Shell Companies industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

OACC

STRONG SELLREMOVE

Oaktree Acquisition Corp. III Life Sciences · Financial Services · United States · $263M · Avg Vol: $46K/d

StockRank

P/E (TTM)

36.8x

ROE

—

D/E

—

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Oaktree Acquisition Corp is a SPAC vehicle. It does not represent an operating business with a durable economic moat or compounding cash flows.

COMPANY DESCRIPTION

Oaktree Acquisition Corp. III Life Sciences is a Special Purpose Acquisition Company (SPAC) explicitly formed to pursue a business combination with a private company in the life sciences sector. Leveraging the expertise of its sponsor, Oaktree Capital Management, the company seeks to identify and acquire a high-potential target within the biotechnology, pharmaceutical, or medical technology industries.

FINANCIAL SUMMARY (USD)

Year	2025
Revenue	0
EPS	0.30
Shares	25M
Debt	11,824
Equity	195M
Op CF	-422,079
Inv CF	500,000
Fin CF	0

PRICE (1M)+0.4%

SMA 50SMA 200

$10.65

RSI (14)

33.3

52W High

$10.74

From 52W High

1.0%

SCORE BREAKDOWN

Quality

ROIC

-0.6%8.2

ROE

—N/A

GP/Assets

—N/A

Op. Margin

0.0%12.9

FCF/Assets

—N/A

Piotroski

—20.6

Int. Cover

—N/A

D/E Ratio

—N/A

Current Ratio

0.87x21.0

Value

P/E (TTM)

36.8x9.7

EV/EBITDA

—N/A

P/FCF

—N/A

P/B

-36.3x96.5

P/S

—N/A

Div Yield

—N/A

Momentum

52W High %

99%92.2

RS 6M

-10%38.3

SMA 50/200

1.00x37.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-16%16.9

FUNDAMENTALS

Market Cap

$263M

P/E (Forward)

—

Gross Margin

0.0%

SECTOR PEERS

Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of OACC are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
OACC	Oaktree Acquisition Corp. III Life Sciences(you)	$263M	13	STRONG SELL
VNME	Vendome Acquisition Corporation I	$255M	13	STRONG SELL
PLMK	Plum Acquisition Corp. IV	$258M	14	STRONG SELL
RAAQ	Real Asset Acquisition Corp.	$262M	15	STRONG SELL
DMAA	Drugs Made In America Acquisition Corp.	$257M	15	STRONG SELL
MACI	Melar Acquisition Corp. I	$234M	13	STRONG SELL
AACB	Artius II Acquisition Inc.	$289M	14	STRONG SELL
HVII	Hennessy Capital Investment Corp. VII	$271M	11	STRONG SELL
DYNC	Dynamix Corporation	$239M	12	STRONG SELL
DNMX	Dynamix Corporation III	$269M	10	STRONG SELL

Peer medians: ROE 10.8% · P/E 13.6x · Gross margin 0.0%

Oaktree Acquisition Corp. III Life Sciences (OACC) — Stock Score Summary

Oaktree Acquisition Corp. III Life Sciences (OACC) has a MoatMap StockRank of 13/100 based on Quality (20/100), Value (33/100), and Momentum (46/100) factor scores. The current signal is STRONG SELL. Oaktree Acquisition Corp is a SPAC vehicle. It does not represent an operating business with a durable economic moat or compounding cash flows.

Key Financial Metrics

Price	$10.65
Market Cap	$263M
P/E (TTM)	36.76
Price/Book	-36.26
Return on Invested Capital	-0.6%
Gross Margin	0.0%
Operating Margin	0.0%

Oaktree Acquisition Corp. III Life Sciences operates in the Shell Companies industry, part of the Financial Services sector (United States).

Frequently Asked Questions

What is Oaktree Acquisition Corp. III Life Sciences’s (OACC) StockRank?: MoatMap’s StockRank for Oaktree Acquisition Corp. III Life Sciences (OACC) is 13/100, with a Strong Sell signal. It is a composite of Quality (20), Value (33), and Momentum (46) factor ranks across MoatMap’s 20,000+ stock universe.
Does Oaktree Acquisition Corp. III Life Sciences have an economic moat?: Oaktree Acquisition Corp. III Life Sciences (OACC) has a Quality factor score of 20/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Oaktree Acquisition Corp. III Life Sciences a buy, hold, or sell?: MoatMap’s current signal for Oaktree Acquisition Corp. III Life Sciences (OACC) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Oaktree Acquisition Corp. III Life Sciences in?: Oaktree Acquisition Corp. III Life Sciences (OACC) operates in the Financial Services sector, specifically the Shell Companies industry (United States).